Corporate News
Staidson Beijing Biopharma (300204.SZ)
- The share price remained unchanged during the 24‑hour period ending 01:56 PM Central Europe on Wednesday 21 October 2026.
- The current trading price is approximately CNY 18.26.
- Outstanding shares total 541.3 million.
- Market capitalization is CNY 9.8 billion.
- Trading volume in the last 24 hours was about CNY 207.3 million.
- Since the end of the previous month the share price has decreased by 13.02 %.
- The 200‑day simple moving average is CNY 22.29.
- The 52‑week high was CNY 41.17 (recorded 11 April 2025).
- The 52‑week low was CNY 17.35 (recorded 19 October 2026).
Related Stock Performance (Last 24 Hours)
| Company | Ticker | 24‑hour movement | Current price | Market cap | P/E ratio | Notes |
|---|---|---|---|---|---|---|
| Freewon China | 688678.SS | Flat | CNY 25.50 | CNY 11.8 bn | 53.48 | Mentioned in recent discussions of AI‑driven hardware and foldable‑screen technologies. |
| Xiamen Leading Optics L | 605118.SS | Flat | CNY 28.29 | CNY 11.8 bn | 42.01 | |
| Shanghai Hanbell Precise | 002158.SZ | Flat | CNY 22.16 | CNY 11.8 bn | 23.99 | |
| Tibet Rhodiola Pharm | 600211.SS | Flat | CNY 36.47 | CNY 11.7 bn | 11.81 | |
| Zhejiang Medicine | 600216.SS | Flat | CNY 12.08 | CNY 11.7 bn | 14.42 |
Company Overview
Staidson Beijing Biopharmaceuticals Co Ltd. is a Chinese health‑care company listed on the Shenzhen Stock Exchange. Founded in 2002 and headquartered in Beijing, the company conducts research, develops, produces, and sells biological products. Its product portfolio includes:
- Su peptide (mouse nerve growth factor injection)
- Shu Tai Qing (polyethylene glycol electrolyte powder for bowel and constipation)
- Shu Wei Yan (trospium chloride capsule for overactive bladder)
- Aspirin enteric‑coated tablets, gliclazide tablets, nabumetone capsules, and other pharmaceuticals
The company’s IPO took place on 15 April 2011. The corporate website is www.staidson.com .